Journals / Dicle Tıp Dergisi / 2019 / Cilt: 46 Sayı: 2

A Case Report: Acute Myopia and Angle-Closure Glaucoma Attack after Topiramate use

Pages
389–392
Publication Date
2019-06-11
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Common complaints include visual disturbances and eye pain.  

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Topiramate acetate is a commonly used drug prescribed by neurologists and psychiatrists for the treatment of various diseases including migraine.
📊
Key Findings & Data:Topiramate therapy can cause a forward displacement of the iris-lens diaphragm which can result in acute bilateral angle-closure glaucoma and myopia.
💡
Conclusion & Impact:Common complaints include visual disturbances and eye pain.  
🔬Design:Olgu Sunumu
📍Scope:Comprehensive Sample
⚙️Variables:Topiramate acetate · angle-closure glaucoma · myopia

Özet

Topiramate acetate is a commonly used drug prescribed by neurologists and psychiatrists for the treatment of various diseases including migraine. Topiramate therapy can cause a forward displacement of the iris-lens diaphragm which can result in acute bilateral angle-closure glaucoma and myopia. Common complaints include visual disturbances and eye pain.  

🔖

Cite This Article

Aslan, A., Keklikçi, U., Bilgen, K. (2019). A Case Report: Acute Myopia and Angle-Closure Glaucoma Attack after Topiramate use. Dicle Tıp Dergisi, Cilt: 46 Sayı: 2, 389–392. https://doi.org/10.5798/dicletip.575024

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Thambi L, Kapcala LP, Chambers W.: Topiramate-associated secondary angle-closure glaucoma: a case series. Arch Ophtalmol. 2002; 120: 1108.
  2. Banta JT, Hoffmn K, Budenz DL.:Presumed topiramate induced bilateral acute angle closure glaucoma. Am J Ophtalmol. 2001; 132: 112-4.
  3. Resnikoff S, Pascolini D, Etya'ale D, et all. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004; 82: 844-51.
  4. Sankar PS, Pasquale LR, Grosskreutz CL.: Uveal effusion and secondary angle-closure glaucoma associated with topiramate use. Arch Ophthalmol. 2001; 119; 1210-1.
  5. Ates H, Kayikcioglu O, Andac K. Bilateral angle closure glaucoma following general anesthesia. Int Ophthalmol 1999; 23: 129-30.
  6. Costagliola C, Parmeggiani F, Semeraro Fi, et all. Selective seratonin reuptake inhibitors: a review of itseffects on intra ocular pressure. Current Neuropharmacology 2008; 6: 293-310.
  7. Reuser T, Flanagan DW, Borland C, et all. Acute angle closure glaucoma occurring after nebulized bronchodilator treatment with ipratropium bromide and salbutamol. J Roy Soc Med 1992; 85: 499-500.
  8. Sbeity Z, Gvozdyuk N, Amde W, et all. Argon laser peripheral iridoplasty for topiramate-induced bilateral acute angle closure. J Glaucoma. 2009; 18: 269-71.
  9. Örüm Ö.,TarakçıoğluH.,Yiğit U.: Myopic Slip Triggered by Topiramate Use and Bilateral Secondary Closed Angled Glaucoma. Turk J Ophthalm ol 2012; 42: 154-6.
  10. Altıparmak UE, Akçalı Hamurcu G, Yılmaz A, Solmaz Şatana B, Duman S. Acute Bilateral Angle Closure GlaucomaDue to Topiramate Use.Glo-Kat. 2007; 2:67-9.